HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Tigazon in the therapy of patients with circumscribed scleroderma].

Abstract
Therapeutic efficacy of tigason in local scleroderma has been demonstrated in 50 patients. The drug has proved effective at all active stages of the process. Its action is favorable in sclerosis and in deep infiltration foci, when traditional therapy, including cuprenil, are of poor efficacy. Tigason altered the course of the disease, making it more benign. The authors recommend this drug, particularly for patients with intolerance of or resistance to the traditional therapy.
AuthorsV A Samsonov, S A Gareginian
JournalVestnik dermatologii i venerologii (Vestn Dermatol Venerol) Issue 11 Pg. 17-20 ( 1990) ISSN: 0042-4609 [Print] Russia (Federation)
Vernacular TitleTigazon v terapii bol'nykh ogranichennoĭ sklerodermieĭ.
PMID2288145 (Publication Type: English Abstract, Journal Article)
Chemical References
  • Etretinate
Topics
  • Adult
  • Aged
  • Atrophy (drug therapy)
  • Chronic Disease
  • Drug Evaluation
  • Etretinate (therapeutic use)
  • Female
  • Humans
  • Male
  • Middle Aged
  • Pigmentation Disorders (drug therapy)
  • Scleroderma, Localized (drug therapy)
  • Skin (pathology)
  • Syndrome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: